Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]

Title: Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]

VOLUME: 8 ISSUE: 1

Author(s):Michael G. Agadjanyan and David H. Cribbs

Affiliation:Molecular Immunology Department University of California The Institute for Molecular Medicine 1207 Gillespie Neuroscience Research Facility Huntington Beach Irvine CA 92647 CA 92697-4540 USA.

Cite this article as:

Michael G. Agadjanyan and David H. Cribbs, “ Editorial [Hot Topic:Active and Passive Aβ-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]”, CNS & Neurological Disorders - Drug Targets (2009) 8: 1. https://doi.org/10.2174/187152709787601849

About this journal